Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
PBH on NYSE
Type / Class
Equity / Common Stock SH
Shares outstanding
49.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
51M
Holdings value
$3.18B
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
348
Number of buys
163
Number of sells
-191
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.2% $609M 7.52M BlackRock, Inc. 31 Mar 2025
ARIEL INVESTMENTS, LLC 7.3% +56% $224M $86.9M 3.59M +63.2% Ariel Investments, LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 5.9% $235M 2.91M Dimensional Fund Advisors LP 31 Dec 2024
MACQUARIE GROUP LTD 4.67% $187M 2.31M Macquarie Group Limited 31 Dec 2024

Institutional Holders of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 51M $3.18B -$64.8M $62.40 348
2025 Q2 52M $4.15B +$68.7M $79.85 372
2025 Q1 51.2M $4.4B -$94.8M $85.97 354
2024 Q4 52.5M $4.1B +$88.6M $78.09 335
2024 Q3 51M $3.68B +$3.2M $72.10 323
2024 Q2 51.1M $3.52B -$4.89M $68.85 305
2024 Q1 51.3M $3.72B +$23.1M $72.56 311
2023 Q4 51.1M $3.13B +$6.37M $61.22 287
2023 Q3 50.9M $2.91B +$55.6M $57.19 279
2023 Q2 49.9M $2.97B -$29.4M $59.43 273
2023 Q1 50.4M $3.15B +$46.8M $62.63 280
2022 Q4 50M $3.13B +$2.11M $62.60 286
2022 Q3 50.1M $2.5B -$37.4M $49.83 270
2022 Q2 50.6M $2.97B +$45.9M $58.80 273
2022 Q1 50.4M $2.67B -$38.1M $52.94 269
2021 Q4 50.5M $3.07B -$86.7M $60.65 261
2021 Q3 50.7M $2.85B -$66.7M $56.11 240
2021 Q2 51.9M $2.71B -$30.9M $52.10 219
2021 Q1 52.6M $2.32B +$13.6M $44.08 233
2020 Q4 52.5M $1.83B -$33.1M $34.87 227
2020 Q3 53.4M $1.94B -$69.4M $36.42 233
2020 Q2 55.3M $2.08B +$31.4M $37.56 248
2020 Q1 54.5M $2B -$232M $36.68 242
2019 Q4 60.6M $2.45B +$57.8M $40.50 223
2019 Q3 60.7M $2.1B -$40.6M $34.69 223
2019 Q2 61.9M $1.96B -$77.9M $31.68 203
2019 Q1 64.7M $1.93B +$6.36M $29.91 212
2018 Q4 64.5M $1.99B -$29.2M $30.88 232
2018 Q3 65.3M $2.48B +$46.6M $37.89 228
2018 Q2 64.1M $2.46B -$15.8M $38.38 227
2018 Q1 65M $2.19B +$74.4M $33.72 231
2017 Q4 62.3M $2.76B +$158M $44.41 246
2017 Q3 58.2M $2.92B +$209M $50.09 237
2017 Q2 53.9M $2.85B +$96.6M $52.81 229
2017 Q1 52.7M $2.93B +$403M $55.56 237
2016 Q4 51.9M $2.7B -$16.5M $52.10 234
2016 Q3 52.3M $2.52B -$14.8M $48.27 241
2016 Q2 52.5M $2.91B -$24.2M $55.40 265
2016 Q1 53.5M $2.86B +$48.5M $53.39 255
2015 Q4 53.2M $2.74B +$7.03M $51.48 234
2015 Q3 53M $2.39B -$5.67M $45.16 205
2015 Q2 53.3M $2.46B -$24M $46.24 202
2015 Q1 54M $2.31B -$38M $42.89 192
2014 Q4 55.2M $1.92B +$23.9M $34.72 175
2014 Q3 54.7M $1.77B +$44.3M $32.37 174
2014 Q2 53.4M $1.81B +$43M $33.89 183
2014 Q1 52.2M $1.42B +$11.8M $27.25 167